User profiles for David Henry

David Henry

Honorary, Bond University, UNSW and UMelbourne, Australia; Emeritus, ICES and …
Verified email at bond.edu.au
Cited by 67539

[HTML][HTML] A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

…, DT Ko, PE Szmitko, PC Austin, JV Tu, DA Henry… - Cmaj, 2009 - Can Med Assoc
Background: Most proton pump inhibitors inhibit the bioactivation of clopidogrel to its active
metabolite. The clinical significance of this drug interaction is unknown. Methods: We …

[HTML][HTML] Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group

…, M Eccles, S Flottorp, GH Guyatt, D Henry… - BMC health services …, 2004 - Springer
Background A number of approaches have been used to grade levels of evidence and the
strength of recommendations. The use of many different approaches detracts from one of the …

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy

DH Henry, NV Dahl, M Auerbach… - The …, 2007 - academic.oup.com
Purpose. To evaluate the safety and efficacy of intravenous (IV) sodium ferric gluconate
complex (FG), oral ferrous sulfate, or no iron to increase hemoglobin (Hb) in anemic cancer …

A 3-year study of high-cost users of health care

WP Wodchis, PC Austin, DA Henry - Cmaj, 2016 - Can Med Assoc
Background: Characterizing high-cost users of health care resources is essential for the
development of appropriate interventions to improve the management of these patients. We …

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

…, P Tugwell, V Welch, E Kristjansson, DA Henry - bmj, 2017 - bmj.com
The number of published systematic reviews of studies of healthcare interventions has
increased rapidly and these are used extensively for clinical and policy decisions. Systematic …

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

…, J Savović, ND Berkman, M Viswanathan, D Henry… - bmj, 2016 - bmj.com
Non-randomised studies of the effects of interventions are critical to many areas of healthcare
evaluation, but their results may be biased. It is therefore important to understand and …

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

…, E Kristjansson, J Grimshaw, DA Henry… - Journal of clinical …, 2009 - Elsevier
OBJECTIVE: Our purpose was to measure the agreement, reliability, construct validity, and
feasibility of a measurement tool to assess systematic reviews (AMSTAR). STUDY DESIGN …

Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion

DA Henry, PA Carless, AJ Moxey… - Cochrane database …, 2011 - cochranelibrary.com
Background Concerns regarding the safety of transfused blood have led to the development
of a range of interventions to minimise blood loss during major surgery. Anti‐fibrinolytic …

Selling sickness: the pharmaceutical industry and disease mongeringCommentary: Medicalisation of risk factors

R Moynihan, P CG, I Heath, D Henry - Bmj, 2002 - bmj.com
… Ray Moynihan, Iona Heath, and David Henry give examples of “disease mongering” and
suggest how to prevent … We thank David Newby for his help in conducting literature searches. …

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

…, JF Viallard, FJ Cuevas, RS Go, DH Henry… - The Lancet, 2008 - thelancet.com
Background Chronic immune thrombocytopenic purpura (ITP) is characterised by accelerated
platelet destruction and decreased platelet production. Short-term administration of the …